AR and posterior cortical atrophy: In fact, patients with PCa with alterations in canonical WNT pathway genes, which lead to β-catenin activation, are refractory to androgen receptor-targeted therapies, underlying that this genomic alteration may harbor a more aggressive cancer [23].